Medication info

Codyquval 160/12.5 mg

Prescription medicationTabletOralExpired
Ingredient · strength
Valsartan›160mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Ahn guk New Pharm Co., Ltd.
Appearance
Dark red oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 201905564 · Approved 2019.08.07

This product's status changed to Expired on 2024.08.07. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension not controlled by monotherapy
Who takes it
Adults
Adult dose
○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg applies when valsartan 160 mg/hydrochlorothiazide 12.5 mg has been prescribed to lower blood pressure. The maximum blood pressure-lowering effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary in patients with mild ~ moderate renal impairment (creatinine clearance of 30 mL/min or greater). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Ingredients

Manufacturer
Ahn guk New Pharm Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by monotherapy

  • Essential hypertension
View approved original text

This medication provides additional blood pressure control for patients with essential hypertension whose blood pressure is not adequately controlled on monotherapy, helping to manage blood pressure reliably. It is used to reduce the risk of cardiovascular complications and improve overall health.

How to take

Adult dose

○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg applies when valsartan 160 mg/hydrochlorothiazide 12.5 mg has been prescribed to lower blood pressure. The maximum blood pressure-lowering effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary in patients with mild ~ moderate renal impairment (creatinine clearance of 30 mL/min or greater). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Precautions

This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately if pregnancy is confirmed. Patients with allergies to this medication or similar drugs, severe liver impairment, or kidney impairment should not take this medication. Patients with impaired kidney or liver function, electrolyte imbalance, elderly patients, and patients with heart disease should use this medication cautiously and require regular check-ups. This medication lowers blood pressure, which can cause dizziness or symptoms of hypotension, therefore care is needed when driving or operating machinery. It can affect potassium levels, so potassium supplements should not be taken without a doctor's instruction, and regular blood electrolyte tests should be conducted. This medication may interact with certain drugs, so if taking other medications, consultation with healthcare professionals is essential. The hydrochlorothiazide component may increase sensitivity to sunlight, raising the risk of skin cancer, therefore sunlight exposure should be avoided, and skin conditions should be checked regularly. Women who are breastfeeding should avoid taking this medication, and safety in pediatric patients has not been established. Overdosing may lead to hypotension, electrolyte abnormalities, muscle cramps, etc., therefore dosage must be strictly adhered to, and any unusual symptoms should be reported to healthcare professionals immediately. This medication should be stored in a tightly sealed container to avoid exposure to air and moisture, and kept in a cool place below 30 degrees Celsius to maintain its efficacy for a long time.

Side effects

Headache, dizziness, nasopharyngitis, fatigue, back pain, cough, upper respiratory tract infection, diarrhea, joint pain, abdominal pain, epigastric pain, blurred vision, visual disturbances, anxiety, arthritis, bronchitis, acute bronchitis, chest pain, orthostatic dizziness, dry mouth, dyspepsia, dyspnea, erectile dysfunction, enteritis, hyperhidrosis, sensory impairment, insomnia, hypokalemia, hypotension, influenza, muscle cramps, muscle sprain, nausea, nasal congestion, nasal bleeding, throat pain, otitis media, limb pain, paresthesia, pharyngodynia, fever, sinus congestion, sinusitis, drowsiness, leg cramps, frequent urination, palpitations, rash, ligament sprain, syncope, tachycardia, tinnitus, urinary tract infection, viral infection, edema, peripheral edema, weakness, angioedema, itching, serum sickness, vasculitis, hair loss, kidney function impairment, myalgia, anaphylaxis-like symptoms, hepatitis, renal failure, hyperkalemia, hyponatremia, shock, loss of consciousness, agranulocytosis, leukopenia, thrombocytopenia, aplastic anemia, hemolytic anemia, necrotizing vasculitis, toxic epidermal necrolysis, interstitial pneumonia, pulmonary edema, exacerbation of systemic lupus erythematosus, hypoglycemia, rhabdomyolysis, elevated AST, palpitations, dyspepsia, edema, weakness, hypertriglyceridemia, increased creatine kinase, decreased hemoglobin, thrombocytopenia, increased serum potassium, dizziness, vasculitis, elevated liver function tests, vesicular dermatitis, joint pain, back pain, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, elevated blood lipids, hypomagnesemia, hyperuricemia, hypercalcemia, hypochloremic alkalosis, decreased appetite, vomiting, abdominal discomfort, constipation, gastrointestinal discomfort, pancreatitis, intrahepatic cholestasis, jaundice, orthostatic hypotension, cardiac arrhythmia, sensory loss, sedation, sleep disturbances, depression, paresthesia, visual impairment, leukopenia, bone marrow failure, acute respiratory distress syndrome, pneumonia, pulmonary edema, acute renal failure, kidney impairment, erythema multiforme, fever, muscle cramps, acute angle-closure glaucoma, nausea, drowsiness, hypovolemia, arrhythmia, muscle stiffness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture from entering, and placed in a cool location below 30 degrees Celsius. This will help preserve the medication's effectiveness for an extended period.

Appearance and packaging

Appearance

Dark red oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.